Sabra Health Care price target raised to $22 from $20 at Citizens JMP

Citizens JMP raised the firm’s price target on Sabra Health Care (SBRA) to $22 from $20 and keeps an Outperform rating on the shares following the Q2 results. The portfolio is performing exceptionally well, with coverage ratios expanding across every category and same-store Senior Housing Operating Portfolio NOI growing by 17%, the analyst tells investors in a research note.